human matrix metalloproteinase 2 Search Results


92
Boster Bio human cd147 bp4745 cytokine
Human Cd147 Bp4745 Cytokine, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd147 bp4745 cytokine/product/Boster Bio
Average 92 stars, based on 1 article reviews
human cd147 bp4745 cytokine - by Bioz Stars, 2025-02
92/100 stars
  Buy from Supplier

94
Shanghai Korain Biotech Co Ltd human matrix metalloproteinase 26
Human Matrix Metalloproteinase 26, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human matrix metalloproteinase 26/product/Shanghai Korain Biotech Co Ltd
Average 94 stars, based on 1 article reviews
human matrix metalloproteinase 26 - by Bioz Stars, 2025-02
94/100 stars
  Buy from Supplier

93
Proteintech matrix metalloproteinase 2
hucMSC-exosomes inhibited intimal hyperplasia and luminal stenosis in arterialized vein grafts. a Representative ultrasound images of vein grafts from the PBS group (left panel) and exosome group (right panel). Quantification of the luminal diameter ( b ) and peak-systolic velocity ( c ) in vein grafts. d Histologic images of haematoxylin and eosin staining (HE) staining in vein grafts from the normal vein group (left panel), PBS group (middle panel), and exosome group (right panel). e Quantification of the neointimal thickness in vein grafts. f Immunohistochemical staining of matrix <t>metalloproteinase</t> <t>2</t> (MMP-2) in vein grafts from the PBS group (left panel) and exosome group (right panel). g Immunohistochemical staining of matrix metalloproteinase 9 (MMP-9) in vein grafts from the PBS group (left panel) and exosome group (right panel). h Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in vein grafts from the PBS group (left panel) and exosome group (right panel). i Quantitative analysis of PCNA-positive index in vein grafts. The PCNA-positive index was quantified as the percentage of total nuclei in the neointima. Scale bar is 200 μm in panels d , f , g , and h . The results are presented as the mean ± SD, n = 6 for each group. An asterisk represents statistically significant difference compared with the PBS group ( P < 0.05). Number sign represents statistically significant difference compared with the normal vein group ( P < 0.05)
Matrix Metalloproteinase 2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/matrix metalloproteinase 2/product/Proteintech
Average 93 stars, based on 1 article reviews
matrix metalloproteinase 2 - by Bioz Stars, 2025-02
93/100 stars
  Buy from Supplier

94
Cusabio human matrix metalloproteinase
hucMSC-exosomes inhibited intimal hyperplasia and luminal stenosis in arterialized vein grafts. a Representative ultrasound images of vein grafts from the PBS group (left panel) and exosome group (right panel). Quantification of the luminal diameter ( b ) and peak-systolic velocity ( c ) in vein grafts. d Histologic images of haematoxylin and eosin staining (HE) staining in vein grafts from the normal vein group (left panel), PBS group (middle panel), and exosome group (right panel). e Quantification of the neointimal thickness in vein grafts. f Immunohistochemical staining of matrix <t>metalloproteinase</t> <t>2</t> (MMP-2) in vein grafts from the PBS group (left panel) and exosome group (right panel). g Immunohistochemical staining of matrix metalloproteinase 9 (MMP-9) in vein grafts from the PBS group (left panel) and exosome group (right panel). h Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in vein grafts from the PBS group (left panel) and exosome group (right panel). i Quantitative analysis of PCNA-positive index in vein grafts. The PCNA-positive index was quantified as the percentage of total nuclei in the neointima. Scale bar is 200 μm in panels d , f , g , and h . The results are presented as the mean ± SD, n = 6 for each group. An asterisk represents statistically significant difference compared with the PBS group ( P < 0.05). Number sign represents statistically significant difference compared with the normal vein group ( P < 0.05)
Human Matrix Metalloproteinase, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human matrix metalloproteinase/product/Cusabio
Average 94 stars, based on 1 article reviews
human matrix metalloproteinase - by Bioz Stars, 2025-02
94/100 stars
  Buy from Supplier

94
Guangzhou JET Bio-Filtration human mmp-2 (matrix metalloproteinase 2) elisa kit
hucMSC-exosomes inhibited intimal hyperplasia and luminal stenosis in arterialized vein grafts. a Representative ultrasound images of vein grafts from the PBS group (left panel) and exosome group (right panel). Quantification of the luminal diameter ( b ) and peak-systolic velocity ( c ) in vein grafts. d Histologic images of haematoxylin and eosin staining (HE) staining in vein grafts from the normal vein group (left panel), PBS group (middle panel), and exosome group (right panel). e Quantification of the neointimal thickness in vein grafts. f Immunohistochemical staining of matrix <t>metalloproteinase</t> <t>2</t> (MMP-2) in vein grafts from the PBS group (left panel) and exosome group (right panel). g Immunohistochemical staining of matrix metalloproteinase 9 (MMP-9) in vein grafts from the PBS group (left panel) and exosome group (right panel). h Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in vein grafts from the PBS group (left panel) and exosome group (right panel). i Quantitative analysis of PCNA-positive index in vein grafts. The PCNA-positive index was quantified as the percentage of total nuclei in the neointima. Scale bar is 200 μm in panels d , f , g , and h . The results are presented as the mean ± SD, n = 6 for each group. An asterisk represents statistically significant difference compared with the PBS group ( P < 0.05). Number sign represents statistically significant difference compared with the normal vein group ( P < 0.05)
Human Mmp 2 (Matrix Metalloproteinase 2) Elisa Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human mmp-2 (matrix metalloproteinase 2) elisa kit/product/Guangzhou JET Bio-Filtration
Average 94 stars, based on 1 article reviews
human mmp-2 (matrix metalloproteinase 2) elisa kit - by Bioz Stars, 2025-02
94/100 stars
  Buy from Supplier

Image Search Results


hucMSC-exosomes inhibited intimal hyperplasia and luminal stenosis in arterialized vein grafts. a Representative ultrasound images of vein grafts from the PBS group (left panel) and exosome group (right panel). Quantification of the luminal diameter ( b ) and peak-systolic velocity ( c ) in vein grafts. d Histologic images of haematoxylin and eosin staining (HE) staining in vein grafts from the normal vein group (left panel), PBS group (middle panel), and exosome group (right panel). e Quantification of the neointimal thickness in vein grafts. f Immunohistochemical staining of matrix metalloproteinase 2 (MMP-2) in vein grafts from the PBS group (left panel) and exosome group (right panel). g Immunohistochemical staining of matrix metalloproteinase 9 (MMP-9) in vein grafts from the PBS group (left panel) and exosome group (right panel). h Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in vein grafts from the PBS group (left panel) and exosome group (right panel). i Quantitative analysis of PCNA-positive index in vein grafts. The PCNA-positive index was quantified as the percentage of total nuclei in the neointima. Scale bar is 200 μm in panels d , f , g , and h . The results are presented as the mean ± SD, n = 6 for each group. An asterisk represents statistically significant difference compared with the PBS group ( P < 0.05). Number sign represents statistically significant difference compared with the normal vein group ( P < 0.05)

Journal: Stem Cell Research & Therapy

Article Title: Exosomes derived from human umbilical cord mesenchymal stem cells inhibit vein graft intimal hyperplasia and accelerate reendothelialization by enhancing endothelial function

doi: 10.1186/s13287-020-01639-1

Figure Lengend Snippet: hucMSC-exosomes inhibited intimal hyperplasia and luminal stenosis in arterialized vein grafts. a Representative ultrasound images of vein grafts from the PBS group (left panel) and exosome group (right panel). Quantification of the luminal diameter ( b ) and peak-systolic velocity ( c ) in vein grafts. d Histologic images of haematoxylin and eosin staining (HE) staining in vein grafts from the normal vein group (left panel), PBS group (middle panel), and exosome group (right panel). e Quantification of the neointimal thickness in vein grafts. f Immunohistochemical staining of matrix metalloproteinase 2 (MMP-2) in vein grafts from the PBS group (left panel) and exosome group (right panel). g Immunohistochemical staining of matrix metalloproteinase 9 (MMP-9) in vein grafts from the PBS group (left panel) and exosome group (right panel). h Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in vein grafts from the PBS group (left panel) and exosome group (right panel). i Quantitative analysis of PCNA-positive index in vein grafts. The PCNA-positive index was quantified as the percentage of total nuclei in the neointima. Scale bar is 200 μm in panels d , f , g , and h . The results are presented as the mean ± SD, n = 6 for each group. An asterisk represents statistically significant difference compared with the PBS group ( P < 0.05). Number sign represents statistically significant difference compared with the normal vein group ( P < 0.05)

Article Snippet: Matrix metalloproteinase-2 (MMP2, 1:200, Proteintech, Wuhan, China) and matrix metalloproteinase-9 (MMP9, 1:200, Proteintech) and proliferating cell nuclear antigen (PCNA, 1:10000, Abcam, UK) immunohistochemical staining was carried out using SP-9100 Detection Kits to figure out neointimal formation in the vein grafts.

Techniques: Staining, Immunohistochemical staining